Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.

BACKGROUND--Patients admitted with acute exacerbation of chronic obstructive pulmonary disease (COPD) are often prescribed ipratropium bromide in combination with a beta 2 agonist such as salbutamol. Studies have not shown any benefit in adding ipratropium bromide to salbutamol in acute exacerbation...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Thorax
Principais autores:	Moayyedi, P., Congleton, J., Page, R. L., Pearson, S. B., Muers, M. F.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC474895/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7570433/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.50.8.834
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!